PR97184

MONROE, Ohio, July 26, 2022 /PRNewswire-AsiaNet/ --

    - Amy DuRoss joins CSafe Global as President, Cell & Gene Therapy to drive

innovation and solution development

CSafe Global [

https://c212.net/c/link/?t=0&l=en&o=3601281-1&h=2454189868&u=https%3A%2F%2Fnam02.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fcsafeglobal.com%252F%26data%3D05%257C01%257Clconaway%2540csafeglobal.com%257Cbe13f6a5ea81469dedd508da6822865b%257C7323859581434d08b2bee4e93edc14d5%257C0%257C0%257C637936794737583660%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C3000%257C%257C%257C%26sdata%3DWleqh9QiP86c8EVbTrYM%252BSkwphBT9AJYuEa5ebTxdHw%253D%26reserved%3D0&a=CSafe+Global

] , the innovation leader in temperature-controlled shipping solutions for the

transport of life-enhancing pharmaceuticals, announced today that Amy DuRoss

has joined the company as President, Cell and Gene Therapies (CGT).

Photo - https://mma.prnewswire.com/media/1864328/Amy_DuRoss.jpg

In her new role, DuRoss will lead CSafe's CGT solutions portfolio to support

intelligent transport of high-value personalized therapies and vaccines to meet

the unprecedented global supply chain transport complexity of CGT products.

Ms. DuRoss brings more than 25 years' experience to her new position. Prior to

joining CSafe, she was the co-founder and CEO of Vineti, an enterprise software

platform used to digitize chain of identity and chain of custody requirements

for CGT products. Earlier in her career, DuRoss held several prestigious

positions including, Chief Business Officer at Navigenics, Chief of Staff for

the California Institute for Regenerative Medicine (CIRM), and Co-Founder,

Co-Author, and Executive Director of California's $3B stem cell research ballot

initiative.

"We are delighted to have Amy leading our CGT team. Her diverse experience in

both corporate development, patient advocacy and entrepreneurship is exactly

the right mix to drive innovation and superior solutions in this deeply complex

supply chain," said CSafe CEO, Patrick Schafer. "We expect to see significant

strides forward in this portfolio under Amy's strategic guidance."

"I'm honored to have the opportunity to collaborate with the world-class team

at CSafe Global in bringing a new standard of high-quality, high-value supply

chain transport to the most exciting innovation area in personalized medicine,

cell and gene therapies," Ms. DuRoss said, "CSafe Global's outstanding

worldwide service network and proven expertise in robust and actionable

analytics to drive supply chain efficiencies will hasten the industrialization

of an emergent market that offers critical hope for an increasing number of

patients in need."

Ms. DuRoss earned her bachelor's and two master's degrees, including her MBA,

from Stanford University. She serves on the boards of Biolife Solutions (BLFS),

MJH, Americans for Cures, and the ARM Foundation and is a member of the Aspen

Institute Global Network.

Media Contact:

Lori Conaway

Global Marketing Communications

+1 405.633.2344

lconaway@csafeglobal.com

About CSafe Global

CSafe Global provides end-to-end thermal shipping solutions to the

pharmaceutical and life science industries worldwide. An industry innovator,

CSafe provides AI-enabled lease forecasting to ensure active container

availability and real-time shipment visibility for customers to monitor

shipments and intervene to preserve a payload when needed. CSafe offers

industry-leading maintenance and reuse programs for active and passive

containers providing superior product performance and alignment with customer

sustainability objectives. With a presence in 150 countries, 24/7 support and

100% container availability, CSafe is well-positioned to be the partner of

choice in the cold chain. http://csafeglobal.com

SOURCE  CSafe Global